update on treatments for high- and low-risk mds
Published 4 years ago • 139 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
11:33
treatment algorithm for low-risk mds
-
3:08
the treatment protocol for higher risk mds
-
3:15
mds: treating high and low-risk disease
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
3:38
a new set of treatment options for low-risk mds
-
55:44
low risk vs high risk mds - what's the difference?
-
11:08
halia therapeutics – eliminating chronic inflammation by targeting the nlrp3 inflammasome
-
45:07
the old and the new in mds management
-
1:20
the current standard of care for patients with lower-risk mds
-
1:51
treatment schedule for ruxolitinib in patients with mpns and how to assess response
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:08
approved and emerging treatment options for transplant-ineligible patients with high-risk mds
-
1:43
reasons why there are fewer treatment options for mds patients and hope for the future
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
2:11
new therapeutic options for low-risk mds
-
4:28
current and emerging treatment options for mds
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
2:07
emerging targeted treatments for mds
-
2:43
novel therapies in the future of mds treatment
-
1:32
next-generation sequencing for low-risk mds
-
2:16
current and future treatment approaches for hr-mds